INTRODUCTION
The ability to make tissue(s) is a necessary feature of stem cells (SCs). Some SCs, such as those of the intestinal epithelium, hematopoietic system, or epidermis, continually generate tissues throughout life. Others, such as those of mammary glands or hair follicles (HFs), undergo less frequent and periodic bouts of regeneration. Regardless of these differences, SC proliferation is tightly regulated to suit the homeostatic needs of their respective tissues, and disruption of this regulation can lead to severe consequences. For example, mutations causing hematopoietic stem cells (HSCs) to hyperproliferate often lead to their exhaustion (Pietras et al., 2011; Yilmaz et al., 2006) , whereas mutations causing insufficient SC activity in HFs results in a failure to regrow the hair coat after rounds of regeneration (Chen et al., 2012) . Elucidating how SC proliferation is governed and delineating the impact of niche components on this process therefore become critical.
Historically, SCs are thought to receive their regulatory cues from neighboring heterologous cells within a defined local microenvironment, referred to as the SC niche (Morrison and Spradling, 2008) . Recent studies suggest that some differentiated progeny of SCs can also be niche components and provide feedback regulation to their SC parents (Hsu and Fuchs, 2012) . For example, in the HF, committed SCs return to the niche, where they form an inner bulge layer of differentiated Keratin6 + (K6 + ) progeny that inhibits the activation of SCs in the outer bulge layer (Hsu et al., 2011) . In the intestinal SC niche, terminally differentiated Paneth cells sandwiched between crypt SCs promote SC self-renewal (Sato et al., 2011) . In the hematopoietic system, differentiated macrophages home back to the bone marrow, where they enforce HSC retention and restrict their movement into the bloodstream (Chow et al., 2011; Winkler et al., 2010) . In Drosophila, differentiating hemocytes provide inhibitory cues to maintain quiescence in their hematopoietic progenitor parents (Mondal et al., 2011) , and in ovary, signals from specialized progeny, polar cells, influence the functions of follicular SCs (Vied et al., 2012) . Altogether, the lineage feedback circuitry that has emerged thus far involves terminally differentiated SC progeny that act locally within the niche. Transit-amplifying cells (TACs) are an undifferentiated population in transition between SCs and differentiated cells. Although feedback circuitry between TACs and SCs has not been described, several aspects of tissue regeneration suggest that such communication would be beneficial for balancing the process. Although proliferation of SCs initiates tissue regeneration, formation of the TAC pool represents a bottleneck step in the process: once TACs are formed, tissue regeneration proceeds with no return. Feedback regulation from TACs might instruct SCs to further replenish downstream lineages and coordinate the self-renewal of SCs during regeneration. In addition, as the major driving force for tissue production, TACs may signal to heterologous cell types to stage an optimal environment for generating tissue. Although attractive, evidence in support of such roles is lacking.
The mouse HF is an ideal system to explore possible communication between SCs and TACs. Each HF cycles between an active phase of tissue production (anagen), destruction (catagen), and rest (telogen) (legend continued on next page) 2014). Hair regeneration is fueled by hair follicle stem cells (HFSCs) in the bulge (Bu-SCs) and a small cluster of cells beneath it, known as the secondary hair germ (HG) (Morris et al., 2004; Rompolas et al., 2013) . In turn, the HG directly abuts a mesenchymal structure, called the dermal papillae (DP) ( Figure 1A ). Many tissues have two populations of SCs with distinctive proliferative characteristics: a more quiescent population that cycles infrequently (quiescent SCs) and a primed population that is more sensitive to activation (primed SCs) (Li and Clevers, 2010) . In HFs, Bu-SCs and HG represent these two respective populations. Bu-SCs and HG share many molecular features. However, HG cells are always first to proliferate upon anagen entry and in vitro generate larger colonies more quickly than Bu-SCs (Greco et al., 2009) .
Both Bu-SCs and HG are quiescent during telogen. At anagen onset, HG responds to cues from DP and becomes active. Lineage-tracing experiments suggest that these proliferation events within HG lead to generation of matrix, the HF's TAC population, which has a molecular signature very different from that of BuSCs/HGs (Greco et al., 2009; Hsu et al., 2011; Lien et al., 2011; Rompolas et al., 2013) . Matrix proliferates rapidly and, after several divisions, progresses to differentiate to make the hair shaft and its inner root sheath (IRS). By contrast, Bu-SCs proliferate 1-2 days later than HG and are the major source for outer root sheath (ORS) cells that encase the newly regenerating HF as it grows downward and expands the distance between bulge and matrix (Hsu et al., 2011; Rompolas et al., 2013) . At catagen, the matrix apoptoses, but some ORS cells are spared, forming a new bulge and a new HG to sustain the next hair cycle. The adjacent old bulge has no HG or DP and serves only as a SC reservoir for use upon injury and a means to anchor the hair generated in the previous cycle (Hsu et al., 2011) .
Several niche components and factors influence hair cycle progression. During telogen, K6 + bulge maintains Bu-SCs in a quiescent state, at least in part through BMP6 and FGF18 (Fantauzzo and Christiano, 2011; Hsu et al., 2011) . The dermis also imposes macroenvironmental inhibitory cues, largely through BMP4 (Plikus et al., 2008) . Overcoming this quiescence threshold to transition from telogen/anagen requires input from DP and adipocyte progenitors that also signal through DP, by transmitting activation cues such as BMP inhibitors, transforming growth factor b (TGF-b), platelet-derived growth factors (PDGFs), and fibroblast growth factor 7/10 (FGF7/10) (Festa et al., 2011; Greco et al., 2009; Oshimori and Fuchs, 2012) . Together, these factors promote HG activation and anagen entry.
Although close proximity between DP and HG explains how HG is activated prior to Bu-SCs (Greco et al., 2009) , it raises a question of how Bu-SCs become activated. When anagen begins, the DP is increasingly pushed downward as the matrix pool emerges and expands and the ORS forms. At the time of Bu-SC activation, DP is even further away from bulge than at anagen entry ( Figure 1A ). Hence, it seems unlikely that the same mechanism triggering HG activation is involved in Bu-SC activation. That said, neither a specific niche cell type nor Bu-SC proliferation-inducing signal has been identified to account for the behavior of these more quiescent SCs during tissue regeneration. In the present study, we explore this fascinating and important issue.
RESULTS

HG and Bulge Stem Cells Exhibit Different Signaling Responses upon Activation
Anagen is subdivided into six substages (AnaI-VI), based upon morphology and length of the regenerating HF (Mü ller-Rö ver et al., 2001) . Morphologically, AnaI resembles telogen except for a slight expansion of HG, as these cells become proliferative. By AnaII, the growing HG starts to produce matrix (LEF1, P-cadherin double-positive) that envelops the DP. Between AnaII and AnaIII, HG structure is no longer obvious, and emerging HF has doubled in size, displacing DP and matrix by at least 100 mm from the bulge. Signs of IRS differentiation appear, and shortly thereafter, hair shaft begins to form (Figures 1A and S1A available online).
To pinpoint the anagen substage at which Bu-SCs proliferate, we conducted BrdU incorporation assays. Bu-SCs began to proliferate at AnaII and peaked by AnaIII; by AnaV, they had returned to quiescence ( Figure 1B ). This activation pattern and timing did not vary with genetic strain or sex (Figures S1B and S1C), implying that Bu-SC activation is selectively and discretely controlled at AnaII onset through AnaIII.
Since DP had already moved away from bulge by AnaII, we asked how Bu-SCs become activated. We first tested whether canonical WNT and TGF-b2 pathways are induced in activated Bu-SCs as they are in activated HG (Greco et al., 2009; Oshimori and Fuchs, 2012) . RT-PCR analyses of Bu-SCs purified at different hair cycle substages showed that neither WNT target Axin2 nor TGF-b2 target Tmeff1 was appreciably elevated at AnaII-III ( Figure S1D ). We next examined known SC quiescence factors in the environs to see whether these might be downregulated. However, Bmp6 and Fgf18 in K6 + bulge and Bmp4 in dermis were maintained if not elevated at this transition, as was BMP target Id1 in Bu-SCs ( Figure S1E ). These results suggested that in sharp contrast to HG, most Bu-SCs do not display elevated WNT or TGF-b responses, nor do they exhibit stronger signs of BMP inhibition upon activation.
We next searched for other pathways that might account for Bu-SC activation. Hedgehog (HH) agonists and/or ectopic dermal Sonic HH (SHH) can induce anagen (Paladini et al., 2005; Sato et al., 1999) , and systemic delivery of pan-HHblocking antibodies delay it (Wang et al., 2000) , suggesting that the HH pathway might be involved. expressed by sensory neurons that innervate the region just above bulge (Brownell et al., 2011; Li et al., 2011) , whereas Indian HH (IHH) and Desert HH (DHH) have been detected in DP (Driskell et al., 2009; Rendl et al., 2005) . Consistent with these reports, activity of HH reporter Gli1-LacZ was observed in DP and cells right above bulge at the telogen/AnaI transition ( Figure 1C, left panel) . Surprisingly, at AnaIII, Gli1-LacZ activity was markedly elevated throughout the entire bulge and hair bulb (right panel). Although LacZ activity remained strong in matrix-TACs, it quickly waned in bulge as anagen progressed ( Figure S1G, upper panel) . Analogously, RT-PCR showed that within Bu-SCs, expression of HH targets Gli1 and Ptch1 peaked specifically at AnaII-III ( Figure 1D ). These findings revealed that the two-step mechanism for SC activation entails not only spatial and temporal differences in activating Bu-SCs versus HG (Greco et al., 2009 ) but also distinct responses to different activation signals.
Overexpression of SHH Results in Aberrant Bu-SC Activation
We next asked whether altering HH pathway activity would perturb timing of Bu-SC activation. For this, we induced ectopic Shh expression in adult skin by cotransducing embryonic day (E) 9.5 epidermis in utero with one lentivirus constitutively expressing tetracycline-inducible transactivator rtTA coupled bicistronically to EGFP and another harboring an H2BRFP transgene and an Shh gene controlled by an rtTA response element (Chang et al., 2013) . When Shh was induced in telogen, precocious anagen was triggered within 40 hr in all cotransduced HFs, whereas control littermates remained in telogen. More importantly, if Shh was induced at AnaV, when control bulge and upper ORS SCs have returned to quiescence (Hsu et al., 2011) , cotransduced HFs sustained SC proliferation and upregulation of Gli1-LacZ (Figures 1E and S1G) . Together, these data suggested that quiescent SCs proliferate in response to elevated SHH.
Bulge Stem Cell Activation Coincides with the Appearance of Transit-Amplifying Progeny that Robustly Express SHH To gain insights into which HH source(s) might be physiologically relevant for Bu-SC activation, we first determined whether BuSCs and cells within the environs alter their Hh expression specifically at AnaII-III ( Figures 1F, 1G , and S1F). In contrast to prior claims (Xiong et al., 2013) , Bu-SCs do not express Shh (Lien et al., 2011) (Figure 1G ). Moreover, from AnaI/III, none of the three Hhs were upregulated in DP or dorsal root ganglia (DRG, harboring cutaneous neuronal cell bodies) ( Figure 1F ). RT-PCR and in situ hybridizations further revealed that Shh was also low/absent in epidermis and in ORS ( Figure 1G ). Similarly, it was barely detectable in HGs of telogen or AnaI HFs. By AnaII, however, Shh was robustly upregulated in HFs, concomitant with matrix specification. Thereafter, Shh expression remained high and restricted to matrix-TACs until their degeneration during catagen ( Figure 1G ).
Lineage tracing further demonstrated that Shh + cells in AnaII
HFs are matrix precursors, given that when Shh-CreER (Harfe et al., 2004 ) was activated at telogen and sustained through anagen for 10 days, Rosa26-YFP + cells first appeared in a subset of AnaII hair bulb cells and later in matrix and IRS of full-anagen HFs ( Figure 1H ). Epidermis, bulge, and entire ORS remained YFP À even under sustained CreER induction. We further confirmed by in situ hybridization that IRS cells do not express Shh. Their YFP marks are due to their YFP + matrix origin: Thus, when Shh-CreER was induced in full anagen and HFs were examined 48 hr later but preceding IRS generation, YFP was restricted to matrix-TACs. Notably, SHH levels in matrix were significantly higher than in cutaneous neurons, as revealed by Shh-CreER activity and RT-PCR ( Figures 1I and S1H ). These data established that (1) epithelial SHH initiates specifically at AnaII in emerging matrix precursors and is sustained in matrix thereafter; (2) Bu-SC proliferation coincides with and is limited to AnaII-III, when matrix is still in relatively close proximity to bulge (less than 200 mm); and (3) HH levels in surrounding cell types remain constant and relatively low throughout anagen (I-VI).
TAC-Derived SHH Is Essential for Bulge Stem Cell Activation
To determine whether SHH produced by downstream TAC progeny is a critical factor in governing SC behavior, we engineered K15-CrePGR; Shh null /fl mice and treated them with RU486 to knock out Shh in Bu-SCs and HG just prior to the 1 st adult anagen entry (referred to as Shh-cKO). Since Shh is not expressed by either Bu-SCs or HG, this strategy leads to specific perturbation of SHH in the emerging matrix formed from HG ( Figures S2A and S2B ), without interfering with SHH from other sources. The dramatic differences in signaling responsiveness underscored the importance of comparing the same anagen substage when investigating SC activity. We did this for all analyses presented herein. In addition, because the 1 st adult hair cycle in mouse backskin is synchronized, we performed analysis on this cycle unless specified. HGs were still activated in AnaI Shh-cKO HFs, suggesting that SHH is dispensable for this step. However, starting from AnaII, Shh-cKO HFs displayed significantly reduced proliferation not only in hair bulb and TACs, but also in Bu-SCs ( Figure 2A ). HFSC marker expression and apoptotic events were comparable to controls ( Figure S2C and data not shown).
To test whether there is a role for neuronal-derived SHH in governing Bu-SC activation, we surgically ablated dorsal cutaneous nerves just prior to anagen onset. By AnaII (5 days after surgery), sensory nerves encasing HFs had degenerated, but Bu-SC proliferation was no different from the sham-operated control side ( Figures 2B and S2D ). Thus, Bu-SC activation relies upon SHH from TACs and not cutaneous sensory nerves.
Previously we showed that signals from the K6 + bulge inhibit HFSC proliferation (Hsu et al., 2011) . To assess relative contributions of K6 + bulge and matrix-TACs to Bu-SC activation, we exploited hair plucking, which removes the K6 + bulge. Interestingly, despite their more distant proximity, HG cells responded to this loss by proliferating within 24 hr and at least a full day prior to Bu-SCs ( Figure 2C ). This result revealed that (1) in the unperturbed niche, inhibitory cues secreted by the K6 + bulge likely reach and influence HG; and (2) Bu-SC activation upon plucking may not simply arise from loss of inhibitory signals but might also require an activation cue. To address whether this cue is TAC-derived SHH, we repeated plucking experiments in ShhcKO mice. During the first 24 hr, plucked Shh-cKO and control HFs both had robust EdU incorporation in HG. However and in striking contrast to control, Shh-cKO Bu-SCs remained quiescent ( Figure 2C ). In situ hybridization confirmed that in plucked control HFs, Shh is induced starting at 24 hr post-plucking, when the HG enlarges and TACs first appear. Gli1 activation in Bu-SCs also showed a 24 hr delay after plucking (Figures S2E and S2F) . Collectively, these data suggested that TAC-derived SHH is essential to trigger Bu-SC proliferation even when inhibitory cues are removed.
Activation of Bulge Stem Cells but Not HG Requires Shh
Pathway Activity in the HF We next wondered whether TAC-derived SHH exerts its effects by activating Bu-SCs directly. We first determined (C) HFs from WT and Shh-cKO were plucked during telogen at day (D) 0, and the proliferative statuses of Bu-SCs and hair bulbs were examined at D1, D2, and D3 post-plucking (n R 2 mice, R 8 HFs per mice). Box-and-whisker plots are as in Figure 1 legend. **p < 0.01; ***p < 0.001. Bulge (Bu), yellow dashed lines; HG or hair bulb (HB), white dashed lines. Scale bars, 30 mm. n.s., not significant.
whether endogenous SHH target genes are altered in BuSCs when SHH is not produced by matrix-TACs. In situ hybridizations showed that Gli1 was downregulated in Shh-cKO HFs.
RT-PCR analysis of purified AnaII Shh-cKO Bu-SCs further revealed that known SHH targets Gli1, Patched-1 (Ptch1), Cyclin D1 (CycD1), and Cyclin D2 (CycD2) were all downregulated, reflective of a loss of SHH signaling within Bu-SCs ( Figures 3A  and S3A ).
Upon SHH binding to its receptor PTCH1, Smoothened (SMO) is derepressed, and GLI transcription factors become activated (Beachy et al., 2010) . We therefore asked whether removal of SHH downstream components from HFs would affect Bu-SC proliferation. Due to its high targeting efficiency, we used Sox9-CreER (Soeda et al., 2010) rather than K15-CrePGR to induce deletion of Smo and Gli2 in telogen HG and Bu-SCs (Figures 3B and 3C ). Data are mean ± SD. n.s., not significant. *p < 0.05; **p < 0.01; ***p < 0.001.
Similar to Shh-cKO HFs, loss of Smo or Gli2 had no major effect on HG activation. Rather, their deficiency resulted in a significant reduction in Bu-SC proliferation at AnaII ( Figure 3D ). Gli1 and Ptch1 expression were downregulated in Smo-cKO and Gli2-cKO Bu-SCs, as expected from their defective SHH signaling ( Figures 3E and 3F ). Axin2 and Tmeff1 expression was maintained, suggesting that WNT and TGF-b signaling operate normally in Bu-SCs deficient for SHH signaling (Figure S3B) . Together, these data favor a requirement for SHH pathway activity in Bu-SC activation.
TACs Also Act on Heterologous Cell Types to Reinforce Other Niche Signaling Pathways In contrast to the marked proliferative defects in AnaII Shh-cKO hair bulbs, proliferation was largely normal in hair bulbs lacking Smo or Gli2 (Figures 2A and 3D) . This difference could not be explained by gene-targeting efficiencies, which were uniformly high. Rather, it raised the possibility that in secreting SHH, emerging TACs may also influence other niche components, which then transmit additional key factors to maintain TAC proliferation.
To gain insights into possible cell type(s) and factors that might mediate such crosstalk, we first examined consequences of depleting TAC Shh on the expression of Gli1 and Ptch1 by various dermal cell types, including fibroblasts, adipocyte precursors, endothelial cells, and DP. DP showed the most dramatic and significant downregulation ( Figures 4A, S3A, and S4A) .
In early embryonic dermis, deficiency in HH signaling diminishes expression of BMP inhibitor NOGGIN (Woo et al., 2012) . Interestingly, we found that in the adult, Noggin was upregulated in DP as HFs transitioned from AnaI/AnaII-III; moreover, when Shh was ablated, this failed to occur ( Figures 4B and 4C ). DPderived Fgf7, encoding another HG activation factor, behaved similarly to Noggin both in expression pattern and in response to loss of matrix-derived SHH. Fgf10 and several other known dermal niche factors including TGF-b2, Pdgfa, and Bmp4 were not altered in this way ( Figures 4B and S4B) .
By contrast, in SMO-deficient HFs, matrix-TACs still expressed Shh, and DP maintained normal levels of Noggin, Fgf7, and Gli1 ( Figures 4D, S4C, and S4D ). This led us to surmise that matrix-derived SHH, still expressed in these mutants, promotes expression of these DP factors, thereby driving expansion of the SMO-deficient hair bulb. Indeed, NOGGIN and FGF7 each partially rescued hair bulb proliferation defects in Shh-cKO HFs ( Figure 4E ). Collectively, these findings showed that once TACs emerge, they secrete SHH to promote hair bulb expansion through DP-TAC crosstalk. When TACs cannot express SHH, this crosstalk is uncoupled, and DP in turn loses its potency to express factors needed to drive hair bulb proliferation.
Bulge Stem Cell Proliferation Relies Directly upon SHH Signaling Rather than Secondary Stimuli Induced by SHH Signaling Given the secondary stimuli produced by SHH-activated DP, we sought to address whether Bu-SC proliferation relies directly upon SHH signaling or upon secondary stimuli generated by SHH. For this, we devised a strategy to perform mosaic inducible To regulate mosaicism, we transduced E9.5 K14rtTA embryos with lentiviruses harboring inducible Smo or control (luciferase) shRNAs coupled with RFP ( Figure 5A ). As such, the potency of knockdown correlated positively with RFP levels and was confined to the epidermal lineage (Beronja et al., 2010; Dow et al., 2012 Figures 5C and 5D ). Together, these data supported an autonomous requirement of SHH signaling for Bu-SC activation and unequivocally demonstrated that TACs directly control the proliferation of Bu-SCs through SHH ( Figure S5C ).
Gas1 Facilitates SHH Reception in Bulge Stem Cells
The dependency of Bu-SCs on SHH signaling was intriguing given that the distance between SHH-transmitting matrix-TACs and bulge reaches $200 mm by the end of AnaIII. To understand how Bu-SCs maintain this long-range sensitivity, we were drawn to GAS1 (growth arrest-specific 1), a GPI-linked membrane coreceptor of PTCH1 that enhances SHH signaling (Allen et al., 2007; Martinelli and Fan, 2007) . Microarray data showed that Gas1 mRNA was enriched in Bu-SCs Greco et al., 2009; Tumbar et al., 2004) . Moreover, chromatin immunoprecipitation and Solexa sequencing (ChIP-seq) indicated that Gas1 is actively transcribed in Bu-SCs but repressed in matrix-TACs (Lien et al., 2011) (Figure S6A ). RT-PCR and immunofluorescence confirmed these findings and further showed that GAS1 is highly expressed not only in Bu-SCs but also in upper ORS, i.e., the future bulge ( Figures 6A and S6B ).
Similar to Smo-or Gli2-cKOs, Gas1 mutants (Gas1 À/À ) displayed significantly reduced proliferation in Bu-SCs but not hair bulb ( Figures 6B and 6C ). Because GAS1 was also present in dermis, we performed epithelial rescue experiments by transducing K14rTA+; Gas1 À/À embryos with a Doxy-regulatable Gas1 cDNA ( Figure 6D ) to assess whether GAS1 is required in the epithelium. When epithelial Gas1 expression was restored at AnaIII, proliferation defects in Gas1 À/À Bu-SCs were rescued, as was their reduced Gli1 and Ptch1 expression ( Figures 6C-6E and S6C). Together, these data demonstrated that GAS1 enhances the ability of Bu-SCs to respond to SHH secreted by TACs.
Consequences of Defective Bulge Proliferation
The lack of HG and Bu-SC proliferation seen upon Shh-cKO ablation translated into a failure in HF down-growth and haircoat recovery. When examined at 5, 18, and 25 days after AnaII, HFs still displayed AnaII morphology, suggesting that the hair cycle was arrested ( Figure S7A and data not shown). The effects on HF regeneration were less severe in Smo-cKO, as expected by the largely uncompromised SHH signaling in DP. However, Smo-cKO HFs were nevertheless shorter than normal and displayed proliferation defects in mature matrix and ORS, which led to a deficit in hair-coat recovery ( Figure S7A ). Thus, even though AnaII hair bulb proliferation was stimulated mainly by DP factors and unperturbed by SMO loss, matrix proliferation in full anagen required SHH signaling in the HF. In contrast to Shh-cKO or Smo-cKO, Gli2-cKO HFs progressed through anagen despite a severe defect in Bu-SC proliferation and displayed normal ORS and matrix proliferation and a normal hair coat, without abnormal apoptosis ( Figure S7A ; data not shown). Similarly, even though the majority of Gas1 À/À mice died before postnatal day (P) 30, HFs from rare surviving mice reached full anagen and displayed normal proliferation in ORS and matrix. These data indicate that for one cycle, Bu-SC proliferation is dispensable for anagen progression and hair regeneration.
To date, all mutations leading to altered HFSC activity affect either temporal activation of HG (Festa et al., 2011; Folgueras et al., 2013; Lowry et al., 2005; Oshimori and Fuchs, 2012) (E) BSA, NOGGIN, or FGF7 was coinjected with Cy5 fluorescent beads (blue) into Shh-cKO skin for 3 days, followed by EdU administration at D3 and analysis at D4 (n = 3 mice per experiment; R 12 HFs per mouse). Bulge, yellow dashed lines; hair bulb, white dashed lines. Box-and-whisker plots are as in Figure 1 legend. Scale bars, 30 mm. Data are mean ± SD. n.s., not significant. *p < 0.05; **p < 0.01; ***p < 0.001.
selectively block Bu-SC proliferation without affecting proliferation in other populations, presenting a unique opportunity to assess whether Bu-SC proliferation has any contributions. We first turned toward a possible defect in ORS, derived mainly from Bu-SCs (Hsu et al., 2011; Rompolas et al., 2013) . Indeed, full-anagen Gli2-cKO HFs are shorter, indicating that their ORS is shorter ( Figure S7A ). Because new bulge and HG of telogen HFs are derived from ORS of the previous anagen (Hsu et al., 2011) , we then followed these Gli2-cKO HFs into 2 nd telogen. The new bulge of Gli2-cKO HFs was of normal size, but HG cell numbers were significantly reduced compared to controls ( Figure 7A ). Moreover, when Gli2 was depleted efficiently after Bu-SCs returned to quiescence (1 st AnaIV), or in the 2 nd telogen prior to hair cycling, HG size in Gli2-cKO HFs was indistinguishable from that in controls ( Figure S7B ). Thus,
B
HF with complete infection although a nonproliferative function of Gli2 cannot be formally excluded, these results favored the view that the defect in HG cell reduction is mainly due to a requirement for GLI2 in Bu-SC proliferation, without which ORS cannot be fully fueled, compromising HG size for the next cycle.
To test whether the new bulge and HG derived from defective Bu-SC proliferation in Gli2-cKO HFs are functionally equivalent to their wild-type (WT) counterparts, we knocked out Gli2 in 1 st telogen, allowed mice to complete one cycle, and then subjected 2 nd telogen Gli2-cKO and control HFs to hair depilation and regeneration assays. With one round of depilation, initial matrix formation was delayed in Gli2-cKO HFs, Bu-SC proliferation was defective, and HF regeneration lagged behind controls. To determine which of these defects were attributable to fewer HG cells formed in Gli2-cKO HFs, we knocked out Gli2 in 2 nd telogen just prior to hair depilation, i.e., when HFs lacked Gli2 but had a normal HG (Gli2-cKO KO2telo ). These Gli2-cKO KO2telo HFs were still defective in Bu-SC proliferation and had shortened ORS length, but matrix formation and regeneration speed were comparable to controls ( Figures 7B and S7C and data not shown). Together, these data indicated that smaller HG size delays anagen progression. More importantly, the findings revealed that quiescent SCs (Bu-SCs) and primed SCs (HG) influence each other's production in an unforeseen way: primed SCs regulate quiescent-SC proliferation by generating its activation center TACs, and in turn, activation of quiescent SCs governs the formation of primed SC formation at the end of the cycle. 
(legend continued on next page)
With a dysfunctional HG and defective Bu-SC proliferation, additional deficits occurred in Gli2-cKO HFs following subsequent rounds of cycling: whether induced by depilation or by natural aging, each Gli2-cKO hair cycle resulted in a gradually smaller HG and dwindling of Bu-SC numbers (Figures 7C-7F) . Some Gli2-cKO HFs failed to regenerate completely, yielding a sparser hair coat relative to controls ( Figure S7D ). These data established that without sufficient input from Bu-SCs, the formations of first a new HG and then Bu-SCs are affected. In addition, the functionality of remaining HFSCs is compromised, manifested by their inability to regenerate new HFs over time. Collectively, these data underscore the critical importance of Bu-SC proliferation in maintaining long-term regeneration capacity of the HF system.
DISCUSSION
Dissecting Complex Niche Circuitry Regulating Stem Cell Behavior
Each SC niche varies in complexity, cell types, and signaling circuitry, which has made their identification and characterization a challenging task, particularly in complex mammalian tissues. Identifying the neighboring cell type(s) surrounding SCs has yielded insights into putative niche compositions (Mé ndez-Ferrer et al., 2010), and interfering with niche components has revealed functional importance of some niche cell types (Hsu et al., 2011; Raaijmakers et al., 2010; Rompolas et al., 2012; Zhang et al., 2003) . Establishing the importance of a specific signal originating from a particular cell type can be achieved in part by selectively deleting a signaling factor from a niche component (Ding and Morrison, 2013; Ding et al., 2012) . However, despite their indisputable value, these strategies do not unearth whether a signal acts directly on SCs or on a different niche cell type, which might then relay secondary signals to SCs. Moreover, if signals are knocked out during embryogenesis and analyzed in adults, it is not easy to distinguish primary from cumulative effects. Here, we attempted to tackle these hurdles by targeting both a signal emanating from the niche and the signal's critical downstream components within SCs. With high precision, we unveiled both direct and indirect functions of a specific niche factor, SHH.
BRG1, a chromatin-remodeling enzyme, has been proposed to form a regulatory loop with SHH to activate each other's expression in HFs (Xiong et al., 2013) . However, HFs lacking Brg1 differ markedly from those lacking Shh: Brg1 mutants produce full-anagen HFs, whereas Shh-cKO HFs arrest in AnaII. Thus, if Shh is ever lost in Brg1 mutants, it must happen in mature anagen, when matrix has moved too far away to influence BuSCs. In addition, Brg1 mutants rapidly lose their hairs during telogen, implying a defect in hair anchorage, not tissue regeneration. By contrast, although HFs cannot regenerate following Shh ablation, old club hairs formed from morphogenesis are maintained for months. Brg1-cKO HFs also display more severe abnormalities than Smo-cKO or Gli2-cKO HFs. Overall, Brg1 phenotypes appear to be complex and likely independent of SHH.
Previous studies highlight the importance of SHH signaling in embryonic HF development (Chiang et al., 1999; Gritli-Linde et al., 2007; Jamora et al., 2003; Mill et al., 2003; St-Jacques et al., 1998) . Some differences arise when comparing SHH's functions in hair morphogenesis and adult hair regeneration: First, although HH signaling induces Noggin in embryonic mesenchyme prior to DP maturation, and as it does in adult DP, this is dispensable for embryonic placode proliferation (Woo et al., 2012) . Second, once DP forms, SHH can act on it to coordinate additional stimuli such as Fgf7. Third, while Gli2 is essential for down-growth of embryonic hair placodes, in adult HFs, it is only required in Bu-SCs and may act redundantly with other Gli transcription factors in other compartments. These comparisons suggest that even though adult SCs have adapted similar pathways that are operative during their development, the functions and mechanisms of action of these pathways can be different, highlighting the importance of using inducible approaches to study adult SC niches.
The Transit-Amplifying Pool Is an Active Signaling Center that Orchestrates Tissue Regeneration Traditionally, TACs have been viewed as passive intermediates in tissue production. Our study unearthed several new and unforeseen functions for TACs that go well beyond the mere generation of terminally differentiated cells. First, we discovered that emerging TACs communicate directly to quiescent SCs and promote their proliferation, a process that happens when TACs are less than 200 mm from the bulge. As the HF grows downward and the ORS elongates, the matrix-TAC pool progressively moves away from the bulge and upper ORS. This provides a convenient mechanism to halt proliferation, so that the upper ORS, the cellular source for new Bu-SC and HG, has gone through only limited rounds of division. By contrast, starting from their emergence, TACs maintain close contact to DP. The TAC-DP crosstalk further promotes TAC proliferation to maximize rapid tissue production.
Collectively, our findings illustrate how a heterologous niche component (DP) can initiate tissue regeneration by stimulating primed SCs to establish a TAC pool, and then how TACs in turn can act as a signaling center to sustain DP signaling needed to expand the TAC pool. Equally important is the dual ability of TACs to stimulate proliferation of quiescent SCs. In this way, TACs are able to govern and integrate the timing and frequency of proliferation within these three epithelial populations: primed SCs, quiescent SCs, and TACs, thereby exquisitely regulating different phases and lineages involved in the regenerative process.
Most if not all tissues must sense different steps of a regeneration program and respond accordingly. In the HF, TACs provide positive signals, whereas differentiated K6 + bulge provides (E) RT-PCR examining levels of Gas1, Gli1, and Ptch1 in FACS-purified AnaIII Bu-SCs from Gas1
, and Gas1 À/À with epidermal rescue of GAS1 expression. Bulge, yellow dashed lines; hair bulb, white dashed lines. Box-and-whisker plots are as in Figure 1 legend. Scale bars, 30 mm. Data are mean ± SD. n.s., not significant. *p < 0.05; **p < 0.01; ***p < 0.001. (legend continued on next page) inhibitory signals to instruct SCs. By having two different progeny along the SC lineage to control tissue production, the SC/TAC/differentiated cell paradigm has a built-in mechanism to both fuel and gauge tissue production during its active phase and resume a quiescent state at its conclusion. By tailoring positive and negative signal providers to suit the particular needs of each tissue, these built-in feedback mechanisms can be an easy and effective way to ensure proper SC behavior during different phases of regeneration.
Extrinsic Mechanisms Regulate the Action of Quiescent versus Primed Stem Cell Populations
Many mammalian tissues, including the hematopoietic system, intestine, and HF, have both quiescent SCs and primed SCs (Buczacki et al., 2013; Fuchs, 2009; Greco et al., 2009; Li and Clevers, 2010; Wilson et al., 2008) . Whether and how signals from the niche dictate the proliferative features of these two populations have remained poorly understood. For the HF, insights into the governance of these two SC populations are now emerging. During telogen, inhibitory cues from both K6 + bulge and dermal tissues impose a strong brake on both SC populations. Stimuli from DP eventually overpower inhibitory signals to activate primed SCs (HG), which respond first and make TACs. This essentially means that primed SCs must be activated and proliferate to a certain degree before the more quiescent ones can be activated. By invoking a dependency of Bu-SC proliferation on TACs and not DP, the more quiescent SCs become buffered from the occasional activation noise that might occur during the prolonged telogen phase. This ensures that influx from more quiescent SCs will not take place before TACs are generated and the regeneration process has been launched.
Coexistence of two SC populations also raises the question of whether contributions from both are essential for regeneration. In the HF, although reduction in primed-SC numbers or compromised primed-SC proliferation delays hair cycle progression right way, we showed here that the first cycle of regeneration takes place effectively without sufficient input from Bu-SCs. Therefore, the importance of Bu-SC proliferation is not to fuel immediate tissue production but rather to renew and maintain a functional pool of both primed and quiescent SCs over time. In this regard, it is intriguing that in male pattern baldness, quiescent SCs are largely normal, but primed-SC numbers shrink (Garza et al., 2011) . Our study now provides functional insights for how this might arise and how this can affect hair regeneration short-term and long-term.
Lastly, although a common strategy to identify potential niche cells often involves searching for neighboring cell types immediately surrounding SCs, our results suggest that the effective range of specific niche signals may be a more important consideration than the distance between SC and specific niche cell types. They also raise a broader question as to whether SC niches should be defined on the basis of their proximity to SCs, their physiological role in SC governance, and whether their regulatory role is direct or indirect. As our knowledge of niche biology continues to expand, it seems reasonable to elaborate on earlier definitions and view the SC niche as a local ecosystem that maintains proper SC behavior though dynamic crosstalk and interactions between a diverse array of both heterologous cell types and SC progeny, which together ensure that tissue regeneration operates optimally and concomitantly with homeostatic and injury demands.
EXPERIMENTAL PROCEDURES
Mice K6-RFP mice were generated by cloning a 7 kb fragment upstream of Krt6a. Other strains used and corresponding references are listed in the Extended Experimental Procedures. PGK-rTA or K14-rTA were activated by feeding mice with Doxy (2 mg/kg) chow with times specified. Sox9-CreER was activated by intraperitoneal (i.p.) injection (200 mg/g tamoxifen in corn oil) for 7-10 days in addition to topical application (20 mg/ml in ethanol) for 2 days. K15-CrePGR activation was by topical application of RU486 (4% in ethanol) for 8-10 days. BrdU (50 mg/g) or EdU (25 mg/g) was injected i.p. for two times within 24 hr before lethal administration of CO 2 . Ultrasound-guided lentiviral injection procedures have been described (Beronja et al., 2010) . All animals were maintained in an AAALAC-approved animal facility, and procedures were performed with IACUC-approved protocols.
Hair Cycle Timing
Subdivisions of hair cycle into six anagen stages were based on Mü ller-Rö ver et al. (2001) . Since hair cycles vary among strains and sexes, stages instead of exact mouse ages were evaluated and carefully monitored for each experiment. Typically 3-5 mice of matched sex were analyzed. To enrich for populations from a specific anagen substage, the first hair cycle backskin was further divided into four quadrants: left-anterior, right-anterior, left-posterior, and right-posterior. The left quadrants were used for fluorescence-activated cell sorting (FACS), and the corresponding right quadrants were embedded in OCT for examination of hair cycle substages to ensure that > 80% of the HFs were in the exact substage indicated.
Statistical Analysis
Data were analyzed and statistics were performed using unpaired two-tailed Student's t test (Prism5 GraphPad). Significant differences between two groups were noted by asterisks (*p < 0.05; **p < 0.01: ***p < 0.001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and seven figures and can be found with this article online at http://dx.doi.org/ 10.1016/j.cell.2014.02.057.
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